03:25:45 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-11-14 Kvartalsrapport 2024-Q3
2024-08-22 Kvartalsrapport 2024-Q2
2024-08-14 Extra Bolagsstämma 2024
2024-05-29 X-dag ordinarie utdelning CIRCA 0.00 NOK
2024-05-28 Årsstämma 2024
2024-05-15 Kvartalsrapport 2024-Q1
2024-02-15 Bokslutskommuniké 2023
2023-11-09 Kvartalsrapport 2023-Q3
2023-08-17 Kvartalsrapport 2023-Q2
2023-05-26 X-dag ordinarie utdelning CIRCA 0.00 NOK
2023-05-25 Årsstämma 2023
2023-05-11 Kvartalsrapport 2023-Q1
2023-02-16 Bokslutskommuniké 2022
2022-11-17 Kvartalsrapport 2022-Q3
2022-08-25 Kvartalsrapport 2022-Q2
2022-06-03 X-dag ordinarie utdelning CIRCA 0.00 NOK
2022-06-02 Årsstämma 2022
2022-05-24 Kvartalsrapport 2022-Q1
2022-03-02 Bokslutskommuniké 2021
2021-11-25 Kvartalsrapport 2021-Q3
2021-08-26 Kvartalsrapport 2021-Q2
2021-06-17 X-dag ordinarie utdelning CIRCA 0.00 NOK
2021-06-16 Årsstämma 2021
2021-05-27 Kvartalsrapport 2021-Q1
2021-03-02 Bokslutskommuniké 2020

Beskrivning

LandNorge
ListaEuronext Growth Oslo
SektorHälsovård
IndustriBioteknik
Circa Group är verksamma inom bioteknik. Bolaget är en utvecklare av biokemikalier som vidare används för omvandling av avfallsmassa till diverse biokemiskt material. Tekniken används inom energisektorn vid olika produktionsprocesser. Bolaget grundades under 2006 och innehar störst verksamhet runtom den europeiska marknaden. Circa Group har sitt huvudkontor i Oslo, Norge.
2024-04-24 16:39:56
OSLO, NORWAY - 25 APRIL 2024 - Sustainable biochemicals company Circa Group AS
(stock symbol: CIRCA) and Merck, a leading science and technology company, are
pleased to announce the finalisation of an agreement for the supply of CyreneTM,
Circa's sustainable, bio-derived industrial solvent.

"The formalisation of this business partnership, which has developed over the
past five-plus years, is an important step forward for the global marketing and
distribution of CyreneTM," said Circa CEO, Bertel Karlstedt "Our goal is to meet
the demand of researchers and organisations around the world looking for an
alternative to harmful solvents, minimise environmental health impact and
simultaneously improve product performance."

CyreneTM is a bio-based solvent that demonstrates circularity, sustainability,
and safety at every stage of its life cycle. From fossil-free non-food feedstock
to its recyclability and end-of-life disposal, it is a safer and more
sustainable alternative to traditional toxic petroleum-based solvents, such as
dimethylformamide (DMF). The DMF market is expected to reach $545.4 million by
2030, growing at an average CAGR of 4.8% between 2024 and 2030. However, there
is growing demand for alternatives given government regulations and concerns
about human health and the environment.

CyreneTM, which is recognized as Sustainability Product of the Year by Business
Intelligence Group's Sustainability Awards and a Top Product by the Environment
+ Energy Leader Awards, is a promising option for various applications.

About Circa
Established in 2006, Circa Group converts waste, non-food biomass into advanced
bio-based chemicals with its proprietary FuracellTM process. Its developing
product portfolio includes flavours, biopolymers, and bio-solvents including
CyreneTM. By creating renewable chemicals from cellulose, Circa is extracting
value from non-food, surplus biomass and contributing to industry as it
transitions to a more circular and decarbonised economy. Circa Group is listed
on the Euronext Growth Market in Oslo, stock symbol CIRCA.
www.circa-group.com

Investor Contact Circa Group

Tone Leivestad, Chief Financial Officer
Circa Group AS
tone.leivestad@circa-group.com
Tel: +47 406 39 455

Media Contact
Kathryn Sheridan
Sustainability Consult
ks@sustainabilityconsult.com